TransDigm (TDG) CFO gets 8,700 options at $1,291.97 strike
TransDigm Group (TDG) reported a Form 4 for CFO Sarah Wynne showing a grant of 8,700 stock options on 11/04/2025 with an exercise price of $1,291.97 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TransDigm Group (TDG) reported a Form 4 for CFO Sarah Wynne showing a grant of 8,700 stock options on 11/04/2025 with an exercise price of $1,291.97 per share.
The options vest 50% in 2029 and 50% in 2030, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. The filing lists direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 8,700 | $0.00 | $0.00 |
Footnotes (1)
- F1. These options are exercisable at 50% per year in 2029 and 50% in 2030 subject to the achievement of annual operating performance targets in each year.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TransDigm (TDG) disclose in this filing?
What is the exercise price of the options granted to TDG’s CFO?
When do the TDG CFO’s options vest?
When do the options expire?
Is the ownership listed as direct or indirect?
Was there any cash price paid for the option grant?
Who is the reporting person in the TDG Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.